Precision Diagnosis of Acute Infectious Diseases; Neuroinflammatory Cohort

Completed · Not applicable

Conditions studied: Encephalitis, Meningitis

In brief

This study aims to use a clinically validated metagenomic next-generation sequencing (mNGS) assay to provide a demonstration of precision medicine for diagnosis of acute infectious disease in hospitalized patients. From June 2016 to June 2017, 200 patients will be enrolled from multiple hospitals in California and outside of California. Patients will be evaluated to determine the impact on the mNGS assay on diagnostic yield, hospital costs and clinical outcomes.

Key facts

Study ID

NCT02910037

Run by

University of California, San Francisco

People needed

214

Starts

2016-06-01

Expected to finish

2017-07-31

Last updated by the study team

2021-05-27

Who can join

Age: any, up to 110. Sex: any. Healthy volunteers: not accepted.

Where it is running

• University of California, Davis Medical Center — Davis, California, United States
• Children's Hospital Los Angeles — Los Angeles, California, United States
• University of California, Los Angeles Medical Center — Los Angeles, California, United States
• University of California, San Francisco Medical Center — San Francisco, California, United States
• Children's Hospital Colordao — Denver, Colorado, United States
• Children's National Medical Center — Washington D.C., District of Columbia, United States
• St. Jude Children's Research Hospital — Nashville, Tennessee, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.